Cytosorbents (CTSO) News Today $1.10 +0.01 (+0.46%) As of 10:11 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTSO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period CytoSorbents Faces Regulatory Challenges for DrugSorb-ATRJuly 5 at 4:52 PM | theglobeandmail.comCytosorbents stock plunges after regulatory setbacks for key deviceJuly 2, 2025 | investing.comCytoSorbents to Appeal Canadian Rejection of License Application for DrugSorb-ATRJuly 2, 2025 | marketwatch.comCytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATRJuly 2, 2025 | prnewswire.comSkylands Capital LLC Raises Holdings in Cytosorbents Corporation (NASDAQ:CTSO)June 29, 2025 | marketbeat.comD. Boral Capital Reiterates "Buy" Rating for Cytosorbents (NASDAQ:CTSO)June 27, 2025 | americanbankingnews.com7CTSO : Deep Dive Into CytoSorbents Stock: Analyst...June 25, 2025 | benzinga.comD. Boral Capital Reaffirms Buy Rating for Cytosorbents (NASDAQ:CTSO)June 25, 2025 | marketbeat.comCytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATRJune 24, 2025 | finanznachrichten.deCytoSorbents Q1 2025 slides: Revenue dips 3% as company targets breakeven by year-end - Investing.comJune 24, 2025 | investing.comCytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATRJune 24, 2025 | prnewswire.comCytosorbents (NASDAQ:CTSO) Share Price Crosses Above 200-Day Moving Average - What's Next?June 24, 2025 | marketbeat.comCytosorbents announces voting results from annual meetingJune 15, 2025 | uk.investing.comCytosorbents (NASDAQ:CTSO) Shares Pass Above Two Hundred Day Moving Average - Here's What HappenedJune 13, 2025 | marketbeat.comCytoSorbents to Participate at the Jefferies Global Healthcare ConferenceMay 29, 2025 | prnewswire.comCytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.comMay 23, 2025 | marketbeat.comCytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025May 22, 2025 | prnewswire.comCTSO: CytoSorbents Reports Strong 1st Quarter 2025 ResultsMay 21, 2025 | finance.yahoo.comCytosorbents FY2025 EPS Forecast Lifted by HC WainwrightMay 21, 2025 | marketbeat.comCytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Call TranscriptMay 16, 2025 | msn.comCytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 16, 2025 | finanznachrichten.deStockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO)May 15, 2025 | marketbeat.comCytosorbents Corporation (CTSO) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comCytoSorbents Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 14, 2025 | prnewswire.comGranahan Investment Management LLC Sells 890,302 Shares of Cytosorbents Co. (NASDAQ:CTSO)May 13, 2025 | marketbeat.comCytosorbents (CTSO) Projected to Post Earnings on WednesdayMay 9, 2025 | marketbeat.comCTSO: CytoSorbents provides regulatory update for DrugSorb-ATR.May 8, 2025 | msn.comCytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.comMay 6, 2025 | marketbeat.comCytosorbents' (CTSO) "Buy" Rating Reaffirmed at D. Boral CapitalMay 4, 2025 | marketbeat.comDemystifying CytoSorbents: Insights From 4 Analyst ReviewsMay 2, 2025 | benzinga.comCytoSorbents Provides Regulatory Update for DrugSorb-ATRMay 1, 2025 | prnewswire.comCytoSorbents to Report First Quarter 2025 Financial Results and Recent Business HighlightsApril 29, 2025 | prnewswire.comCytoSorbents gets $1.7M from New Jersey business tax certificate transfer programApril 21, 2025 | msn.comCytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer ProgramApril 21, 2025 | prnewswire.comCytosorbents (NASDAQ:CTSO) Now Covered by StockNews.comApril 20, 2025 | marketbeat.comCytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate ControllerApril 17, 2025 | prnewswire.comCytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North AmericaApril 14, 2025 | prnewswire.comCytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.comApril 13, 2025 | marketbeat.comAnalysts Offer Predictions for Cytosorbents Q1 EarningsApril 8, 2025 | marketbeat.comBrokers Offer Predictions for Cytosorbents Q1 EarningsApril 8, 2025 | marketbeat.comHC Wainwright Predicts Cytosorbents FY2028 EarningsApril 6, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Given "Neutral" Rating at HC WainwrightApril 5, 2025 | marketbeat.comCTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.April 4, 2025 | finance.yahoo.comCytoSorbents Extends Expiration Date of Outstanding Series B Right WarrantsApril 4, 2025 | prnewswire.comCytosorbents' (CTSO) Buy Rating Reiterated at D. Boral CapitalApril 2, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPSApril 1, 2025 | marketbeat.comCytoSorbents reports Q4 adjusted EPS (3c) vs. (17c) last yearApril 1, 2025 | markets.businessinsider.comCytosorbents Corporation (NASDAQ:CTSO) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comCytosorbents Corporation (CTSO) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comCytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsMarch 31, 2025 | prnewswire.com Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address CTSO Media Mentions By Week CTSO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTSO News Sentiment▼0.120.58▲Average Medical News Sentiment CTSO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTSO Articles This Week▼42▲CTSO Articles Average Week Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NNOX News Today ZIMV News Today SNWV News Today CATX News Today NYXH News Today DRTS News Today SMTI News Today BWAY News Today SKIN News Today TCMD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTSO) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytosorbents With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
